Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a palm extract help fight a rare genetic brain disease?

NCT ID NCT04658823

First seen Feb 02, 2026 · Last updated Jun 15, 2026 · Updated 17 times

Summary

This study tested a supplement called HOV-12020 (made from palm tocotrienols) in 50 adults aged 45-75 with CADASIL, a rare genetic disease that damages small blood vessels in the brain, leading to strokes and memory loss. The goal was to see if the supplement could reduce worsening of symptoms like stroke, disability, or cognitive decline over 24 months. Participants were randomly assigned to receive either the supplement or a placebo, and neither they nor their doctors knew which they received.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CADASIL are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hôpital Lariboisière APHP

    Paris, 75010, France

Conditions

The condition(s) this trial relates to.

cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Cerebral Small Vessel Diseases cerebrovascular disorder Cognitive Dysfunction dementia stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.